BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22526649)

  • 1. An automated method for the measurement of a range of tyrosine kinase inhibitors in human plasma or serum using turbulent flow liquid chromatography-tandem mass spectrometry.
    Couchman L; Birch M; Ireland R; Corrigan A; Wickramasinghe S; Josephs D; Spicer J; Flanagan RJ
    Anal Bioanal Chem; 2012 Jun; 403(6):1685-95. PubMed ID: 22526649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An automated method for the simultaneous measurement of azole antifungal drugs in human plasma or serum using turbulent flow liquid chromatography-tandem mass spectrometry.
    Couchman L; Buckner SL; Morgan PE; Ceesay MM; Pagliuca A; Flanagan RJ
    Anal Bioanal Chem; 2012 Aug; 404(2):513-23. PubMed ID: 22695504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid chromatography coupled with tandem mass spectrometry.
    Lankheet NA; Hillebrand MJ; Rosing H; Schellens JH; Beijnen JH; Huitema AD
    Biomed Chromatogr; 2013 Apr; 27(4):466-76. PubMed ID: 22987603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
    Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC/MS-MS.
    Bouchet S; Chauzit E; Ducint D; Castaing N; Canal-Raffin M; Moore N; Titier K; Molimard M
    Clin Chim Acta; 2011 May; 412(11-12):1060-7. PubMed ID: 21345336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An automated method for measurement of methoxetamine in human plasma by use of turbulent flow on-line extraction coupled with liquid chromatography and mass spectrometric detection.
    Abe E; Ricard F; Darrouzain F; Alvarez JC
    Anal Bioanal Chem; 2013 Jan; 405(1):239-45. PubMed ID: 23079952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of 11 Therapeutic Kinase Inhibitors in Human Plasma for Therapeutic Drug Monitoring Using Liquid Chromatography Coupled With Tandem Mass Spectrometry.
    Herbrink M; de Vries N; Rosing H; Huitema AD; Nuijen B; Schellens JH; Beijnen JH
    Ther Drug Monit; 2016 Dec; 38(6):649-656. PubMed ID: 27749781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and clinical application of a LC-MS/MS method for simultaneous determination of various tyrosine kinase inhibitors in human plasma.
    Götze L; Hegele A; Metzelder SK; Renz H; Nockher WA
    Clin Chim Acta; 2012 Jan; 413(1-2):143-9. PubMed ID: 21945732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring.
    Zhang M; Liu X; Chen Z; Jiang S; Wang L; Tao M; Miao L
    J Pharm Biomed Anal; 2022 Mar; 211():114562. PubMed ID: 35124453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of selected tyrosine kinase inhibitors with corticosteroids and antiemetics in rat plasma by solid phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic interaction studies.
    Maher HM; Alzoman NZ; Shehata SM
    J Pharm Biomed Anal; 2016 May; 124():216-227. PubMed ID: 26966895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A validated assay for the simultaneous quantification of six tyrosine kinase inhibitors and two active metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.
    van Erp NP; de Wit D; Guchelaar HJ; Gelderblom H; Hessing TJ; Hartigh Jd
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 937():33-43. PubMed ID: 24013127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring.
    Koller D; Vaitsekhovich V; Mba C; Steegmann JL; Zubiaur P; Abad-Santos F; Wojnicz A
    Talanta; 2020 Feb; 208():120450. PubMed ID: 31816725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Simultaneous Quantification Method of 14 Tyrosine Kinase Inhibitors in Human Plasma Using LC-MS/MS.
    Huynh HH; Pressiat C; Sauvageon H; Madelaine I; Maslanka P; Lebbé C; Thieblemont C; Goldwirt L; Mourah S
    Ther Drug Monit; 2017 Feb; 39(1):43-54. PubMed ID: 27861317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
    Aghai F; Zimmermann S; Kurlbaum M; Jung P; Pelzer T; Klinker H; Isberner N; Scherf-Clavel O
    Anal Bioanal Chem; 2021 Jan; 413(2):599-612. PubMed ID: 33155133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous Determination of Imatinib, Dasatinib, and Nilotinib by Liquid Chromatography-Tandem Mass Spectrometry and Its Application to Therapeutic Drug Monitoring.
    Wojnicz A; Colom-Fernández B; Steegmann JL; Muñoz-Calleja C; Abad-Santos F; Ruiz-Nuño A
    Ther Drug Monit; 2017 Jun; 39(3):252-262. PubMed ID: 28490048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS.
    Andriamanana I; Gana I; Duretz B; Hulin A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 926():83-91. PubMed ID: 23562906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrafast Online SPE-MS/MS Method for Quantification of 3 Tyrosine Kinase Inhibitors in Human Plasma.
    Vrobel I; Janečková H; Faber E; Bouchalová K; Mičová K; Friedecký D; Adam T
    Ther Drug Monit; 2016 Aug; 38(4):516-24. PubMed ID: 27414975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple and selective method for the determination of various tyrosine kinase inhibitors used in the clinical setting by liquid chromatography tandem mass spectrometry.
    Honeywell R; Yarzadah K; Giovannetti E; Losekoot N; Smit EF; Walraven M; Lind JS; Tibaldi C; Verheul HM; Peters GJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1059-68. PubMed ID: 20382575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rugged and accurate quantitation of colchicine in human plasma to support colchicine poisoning monitoring by using turbulent-flow LC-MS/MS analysis.
    Bourgogne E; Soichot M; Latour C; Laprévote O
    Bioanalysis; 2013 Dec; 5(23):2889-96. PubMed ID: 24295116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assay.
    Zhao M; Rudek MA; He P; Hafner FT; Radtke M; Wright JJ; Smith BD; Messersmith WA; Hidalgo M; Baker SD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):1-7. PubMed ID: 16798122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.